← Evidence map

ArticleChina CDC weekly2026

Financial Feasibility of BPaL(M) Under Pretomanid Price Scenarios - China, 2023-2024.

Jingjuan Ren et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Full record →Abstract, authors, funding and every citing paper · PMID 42245279